TY - JOUR
T1 - The serotonin receptor 2A (HTR2A) rs6313 variant is associated with higher ongoing pain and signs of central sensitization in neuropathic pain patients
AU - Sachau, Juliane
AU - Bruckmueller, Henrike
AU - Gierthmühlen, Janne
AU - Magerl, Walter
AU - May, Denisa
AU - Binder, Andreas
AU - Forstenpointner, Julia
AU - Koetting, Judith
AU - Maier, Christoph
AU - Tölle, Thomas R.
AU - Treede, Rolf Detlef
AU - Berthele, Achim
AU - Caliebe, Amke
AU - Diesch, Carolin
AU - Flor, Herta
AU - Huge, Volker
AU - Maihöfner, Christian
AU - Rehm, Stefanie
AU - Kersebaum, Dilara
AU - Fabig, Sophie Charlotte
AU - Vollert, Jan
AU - Rolke, Roman
AU - Stemmler, Susanne
AU - Sommer, Claudia
AU - Westermann, Andrea
AU - Cascorbi, Ingolf
AU - Baron, Ralf
N1 - Publisher Copyright:
© 2020 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC ®
PY - 2021/3
Y1 - 2021/3
N2 - Background: The serotonin receptor 2A (HTR2A) has been described as an important facilitation mediator of spinal nociceptive processing leading to central sensitization (CS) in animal models of chronic pain. However, whether HTR2A single nucleotide variants (SNVs) modulate neuropathic pain states in patients has not been investigated so far. The aim of this study was to elucidate the potential association of HTR2A variants with sensory abnormalities or ongoing pain in neuropathic pain patients. Methods: At total of 240 neuropathic pain patients and 253 healthy volunteers were included. Patients were phenotypically characterized using standardized quantitative sensory testing (QST). Patients and controls were genotyped for HTR2A g.-1438G > A (rs6311) and c.102C > T (rs6313). Genotype-related differences in QST parameters were assessed considering QST profile clusters, principal somatosensory components and sex. Results: There was an equal distribution of rs6313 and linked rs6311 between patients and controls. However, the rs6313 variant was significantly associated with a principal component of pinprick hyperalgesia and dynamic mechanical allodynia, indicating enhanced CS in patients with sensory loss (−0.34 ± 0.15 vs. +0.31 ± 0.11 vs., p <.001). In this cluster, the variant allele was also associated with single QST parameters of pinprick hyperalgesia (MPT, +0.64 ± 0.18 vs. −0.34 ± 0.23 p =.002; MPS, +0.66 ± 0.17 vs. −0.09 ± 0.23, p =.009) and ongoing pain was increased by 30%. Conclusions: The specific association of the rs6313 variant with pinprick hyperalgesia and increased levels of ongoing pain suggests that the HTR2A receptor might be an important modulator in the development of CS in neuropathic pain. Significance: This article presents new insights into serotonin receptor 2A-mediating mechanisms of central sensitization in neuropathic pain patients. The rs6313 variant allele was associated with increased mechanical pinprick sensitivity and increased levels of ongoing pain supporting a contribution of central sensitization in the genesis of ongoing pain providing a possible route for mechanism-based therapies.
AB - Background: The serotonin receptor 2A (HTR2A) has been described as an important facilitation mediator of spinal nociceptive processing leading to central sensitization (CS) in animal models of chronic pain. However, whether HTR2A single nucleotide variants (SNVs) modulate neuropathic pain states in patients has not been investigated so far. The aim of this study was to elucidate the potential association of HTR2A variants with sensory abnormalities or ongoing pain in neuropathic pain patients. Methods: At total of 240 neuropathic pain patients and 253 healthy volunteers were included. Patients were phenotypically characterized using standardized quantitative sensory testing (QST). Patients and controls were genotyped for HTR2A g.-1438G > A (rs6311) and c.102C > T (rs6313). Genotype-related differences in QST parameters were assessed considering QST profile clusters, principal somatosensory components and sex. Results: There was an equal distribution of rs6313 and linked rs6311 between patients and controls. However, the rs6313 variant was significantly associated with a principal component of pinprick hyperalgesia and dynamic mechanical allodynia, indicating enhanced CS in patients with sensory loss (−0.34 ± 0.15 vs. +0.31 ± 0.11 vs., p <.001). In this cluster, the variant allele was also associated with single QST parameters of pinprick hyperalgesia (MPT, +0.64 ± 0.18 vs. −0.34 ± 0.23 p =.002; MPS, +0.66 ± 0.17 vs. −0.09 ± 0.23, p =.009) and ongoing pain was increased by 30%. Conclusions: The specific association of the rs6313 variant with pinprick hyperalgesia and increased levels of ongoing pain suggests that the HTR2A receptor might be an important modulator in the development of CS in neuropathic pain. Significance: This article presents new insights into serotonin receptor 2A-mediating mechanisms of central sensitization in neuropathic pain patients. The rs6313 variant allele was associated with increased mechanical pinprick sensitivity and increased levels of ongoing pain supporting a contribution of central sensitization in the genesis of ongoing pain providing a possible route for mechanism-based therapies.
UR - http://www.scopus.com/inward/record.url?scp=85097015140&partnerID=8YFLogxK
U2 - 10.1002/ejp.1696
DO - 10.1002/ejp.1696
M3 - Article
C2 - 33171011
AN - SCOPUS:85097015140
SN - 1090-3801
VL - 25
SP - 595
EP - 611
JO - European Journal of Pain
JF - European Journal of Pain
IS - 3
ER -